Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Linda Burkly currently holds 62,369 shares of Editas Medicine, Inc. (EDIT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Linda Burkly has been a net seller of EDIT stock. They have purchased $0 and sold $95.2K worth of shares.
Linda Burkly's most recent insider trade was on Jul 28, 2026, when they sold 4,928 shares at $2.67 per share.
Linda Burkly serves as Executive at Editas Medicine, Inc. (EDIT). They have executed 10 insider transactions totaling $95.2K over their tenure at the company.
Linda Burkly holds the position of Executive at Editas Medicine, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Linda Burkly has shown a selling trading pattern, with $0 in total purchases and $95.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Linda Burkly was on Jul 25, 2024, when they sold $64.4K worth of EDIT shares. This transaction involved 11,886 shares at $5.42 per share.
Linda Burkly currently owns 62,369 shares of Editas Medicine, Inc. (EDIT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Linda Burkly's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Linda Burkly has 10 Form 4 filings on record as an insider at Editas Medicine, Inc..
Set alerts for Linda Burkly and 40,000+ other insiders.